About
Technology
Issues
FAQ
Links
Official Page
Long‐term
efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled
52‐week
outcomes from the
DEPICT
‐1 and ‐2 studies
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.